Optimizing the science of drug development: opportunities for better candidate selection and accelerated evaluation in humans
Pharm Res
.
2000 Nov;17(11):1335-44.
doi: 10.1023/a:1007574217260.
Authors
L J Lesko
1
,
M Rowland
,
C C Peck
,
T F Blaschke
Affiliation
1
Office of Clinical Pharmacology and Biopharmaceutics, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20851, USA.
PMID:
11205725
DOI:
10.1023/a:1007574217260
No abstract available
Publication types
Review
MeSH terms
Animals
Clinical Trials as Topic / methods*
Drug Design
Drug Evaluation, Preclinical / methods*
Humans
Pharmacokinetics
Pharmacology, Clinical / methods*